Adverum Biotechnologies, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2023: USD -128.97 M

Adverum Biotechnologies, Inc. EBIT is USD -128.97 M for the Trailing 12 Months (TTM) ending September 30, 2023. EBIT means earnings before interest and taxes, it is calculated as operating income plus non-operating income.
  • Adverum Biotechnologies, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2021 was USD -147.65 M.
  • Adverum Biotechnologies, Inc. EBIT for the Trailing 12 Months (TTM) ending September 30, 2019 was USD -60.70 M, a -16.86% change year over year.
Key Data
Date EBIT EBITDA Net Income EPS (Diluted)